227 related articles for article (PubMed ID: 7477874)
21. Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age.
Eastwood SL; Weickert CS; Webster MJ; Herman MM; Kleinman JE; Harrison PJ
Hippocampus; 2006; 16(8):645-54. PubMed ID: 16807900
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia.
Eastwood SL; Harrison PJ
Neuroscience; 1998 Sep; 86(2):437-48. PubMed ID: 9881859
[TBL] [Abstract][Full Text] [Related]
23. The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry.
Zaidel DW; Esiri MM; Harrison PJ
Psychol Med; 1997 May; 27(3):703-13. PubMed ID: 9153690
[TBL] [Abstract][Full Text] [Related]
24. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes.
Eastwood SL; Heffernan J; Harrison PJ
Mol Psychiatry; 1997 Jul; 2(4):322-9. PubMed ID: 9246673
[TBL] [Abstract][Full Text] [Related]
25. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
Osimo EF; Beck K; Reis Marques T; Howes OD
Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar synaptic protein expression in schizophrenia.
Eastwood SL; Cotter D; Harrison PJ
Neuroscience; 2001; 105(1):219-29. PubMed ID: 11483314
[TBL] [Abstract][Full Text] [Related]
27. Synaptophysin immunoreactivity in temporal lobe epilepsy-associated hippocampal sclerosis.
Looney MR; Dohan FC; Davies KG; Seidenberg M; Hermann BP; Schweitzer JB
Acta Neuropathol; 1999 Aug; 98(2):179-85. PubMed ID: 10442558
[TBL] [Abstract][Full Text] [Related]
28. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro.
Rozovsky I; Morgan TE; Willoughby DA; Dugichi-Djordjevich MM; Pasinetti GM; Johnson SA; Finch CE
Neuroscience; 1994 Oct; 62(3):741-58. PubMed ID: 7870303
[TBL] [Abstract][Full Text] [Related]
29. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
[TBL] [Abstract][Full Text] [Related]
30. Progressive reduction of synaptophysin message in single neurons in Alzheimer disease.
Callahan LM; Vaules WA; Coleman PD
J Neuropathol Exp Neurol; 2002 May; 61(5):384-95. PubMed ID: 12025941
[TBL] [Abstract][Full Text] [Related]
31. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies.
Lippa CF
Am J Alzheimers Dis Other Demen; 2004; 19(6):341-4. PubMed ID: 15633942
[TBL] [Abstract][Full Text] [Related]
32. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.
Bachus SE; Hyde TM; Herman MM; Egan MF; Kleinman JE
J Psychiatr Res; 1997; 31(2):233-56. PubMed ID: 9278188
[TBL] [Abstract][Full Text] [Related]
33. Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
Blennow K; Bogdanovic N; Heilig M; Grenfeldt B; Karlsson I; Davidsson P
J Neural Transm (Vienna); 2000; 107(8-9):1085-97. PubMed ID: 11041284
[TBL] [Abstract][Full Text] [Related]
34. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
[TBL] [Abstract][Full Text] [Related]
35. GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy.
Muñoz A; Arellano JI; DeFelipe J
J Comp Neurol; 2002 Jul; 449(2):166-79. PubMed ID: 12115687
[TBL] [Abstract][Full Text] [Related]
36. Expression of presynaptic markers in a neurodevelopmental animal model with relevance to schizophrenia.
Karlsen AS; Kaalund SS; Møller M; Plath N; Pakkenberg B
Neuroreport; 2013 Nov; 24(16):928-33. PubMed ID: 24045778
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between hippocampal mossy fiber sprouting and synaptic reorganization and mechanisms of temporal lobe epilepsy].
Lin H; Wu LW; Huang YG; Chen YC; Wen XN
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):341-4. PubMed ID: 17456365
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy.
Proper EA; Oestreicher AB; Jansen GH; Veelen CW; van Rijen PC; Gispen WH; de Graan PN
Brain; 2000 Jan; 123 ( Pt 1)():19-30. PubMed ID: 10611117
[TBL] [Abstract][Full Text] [Related]
39. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
[TBL] [Abstract][Full Text] [Related]
40. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.
Eastwood SL; Kerwin RW; Harrison PJ
Biol Psychiatry; 1997 Mar; 41(6):636-43. PubMed ID: 9066986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
